SCHEMBL22095449

SCHEMBL22095449

O=P(O)(Cc1ccccc1)c1cnccn1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 2/20 0.41
FDPS P14324 7/20 0.41
LMNA P02545 1/20 0.40
BTN3A1 O00481 1/20 0.40
PDE3A Q14432 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ALPL P05186 1/20 0.38
ALPI P09923 1/20 0.38
ALPG P10696 1/20 0.38
HTT P42858 1/20 0.38
KDM4C Q9H3R0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8337291 0.70 KDM4E (0.41) MEN1KMT2AFDPSLMNASMN1; SMN2
SCHEMBL6448091 0.69 CFTR (0.64) HPGDMEN1KMT2AALDH1A1FDPS
SCHEMBL22990157 0.67 CA1 (0.45) MEN1KMT2AALDH1A1LMNASMN1; SMN2
SCHEMBL22990166 0.67 CA1 (0.45) MEN1KMT2AALDH1A1LMNASMN1; SMN2
Benzylphosphonic Acid SCHEMBL44318 0.66 HPGD (0.60) HPGD
SCHEMBL497159 0.66 HPGD (0.60) HPGDFDPS
SCHEMBL29201710 0.65 CFTR (0.64) HPGDMEN1KMT2AALDH1A1
SCHEMBL9546859 0.65 FDPS (0.66) FDPSBTN3A1PDE3A
Benzylphosphonic Acid SCHEMBL6442960 0.65 ROCK2 (0.50) HPGDSMN1; SMN2ALPLALPIALPG
Benzylphosphonic Acid SCHEMBL6442957 0.65 ROCK2 (0.50) HPGDSMN1; SMN2ALPLALPIALPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3893872-A1 ORGANOPHOSPHORUS-SUBSTITUTED COMPOUNDS AS C-MET INHIBITORS AND THERAPEUTIC USES THEREOF Beta Pharma, Inc. (US) 2021-10-20 EP disclosed
WO-2020124060-A1 ORGANOPHOSPHORUS-SUBSTITUTED COMPOUNDS AS C-MET INHIBITORS AND THERAPEUTIC USES THEREOF BETA PHARMA, INC. (US) 2020-06-18 WO disclosed